Cegedim SA
PAR:CGM

Watchlist Manager
Cegedim SA Logo
Cegedim SA
PAR:CGM
Watchlist
Price: 12.8 EUR -1.16%
Market Cap: 175.5m EUR
Have any thoughts about
Cegedim SA?
Write Note
Section:
 

Relative Value

The Relative Value of one CGM stock under the Base Case scenario is 51.4 EUR. Compared to the current market price of 12.8 EUR, Cegedim SA is Undervalued by 75%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CGM Relative Value
Base Case
51.4 EUR
Undervaluation 75%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.3
P/S
P/S
Price to Sales
0.3
vs History
98
vs Industry
85
Median 3Y
0.4
Median 5Y
0.5
Industry
2.3
Forward
0.3
More Details
87.1
P/E
P/E
Price to Earnings
87.1
vs History
12
vs Industry
28
Median 3Y
19.2
Median 5Y
19.3
Industry
23.1
Forward
10.4
More Details
1.9
P/OCF
P/OCF
Price to OCF
1.9
vs History
98
vs Industry
52
Median 3Y
2.7
Median 5Y
3.1
Industry
14.2
More Details
3.6
P/FCFE
P/FCFE
Price to FCFE
3.6
vs History
60
vs Industry
20
Median 3Y
23.2
Median 5Y
15
Industry
20.1
More Details
0.6
P/B
P/B
Price to Book Value
0.6
vs History
98
vs Industry
73
Median 3Y
0.9
Median 5Y
1.3
Industry
2.2
More Details
0.6
EV/S
EV/S
Enterprise Value to Sales
0.6
vs History
98
vs Industry
75
Median 3Y
0.8
Median 5Y
0.9
Industry
2.4
Forward
0.6
More Details
3.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.4
vs History
93
vs Industry
56
Median 3Y
4.2
Median 5Y
4.6
Industry
5
More Details
3.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
3.8
vs History
84
vs Industry
48
Median 3Y
4.4
Median 5Y
4.6
Industry
12.7
Forward
3.3
More Details
20.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.3
vs History
26
vs Industry
24
Median 3Y
18.8
Median 5Y
15.7
Industry
17.1
Forward
12.4
More Details
4.4
EV/OCF
EV/OCF
Enterprise Value to OCF
4.4
vs History
96
vs Industry
49
Median 3Y
4.7
Median 5Y
5.2
Industry
14
More Details
32
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
32
vs History
23
vs Industry
25
Median 3Y
18.1
Median 5Y
17.7
Industry
18
More Details
0.5
EV/IC
EV/IC
Enterprise Value to IC
0.5
vs History
98
vs Industry
77
Median 3Y
0.6
Median 5Y
0.7
Industry
1.9
More Details

Multiples Across Competitors

CGM Competitors Multiples
Cegedim SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Cegedim SA
PAR:CGM
176.9m EUR 0.3 87.1 3.8 20.3
US
Veeva Systems Inc
NYSE:VEEV
36.3B USD 13.7 54.6 46.3 49
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
26.6B AUD 160.4 322.2 225 225
US
Doximity Inc
NYSE:DOCS
10.8B USD 20.9 62 47.1 49.5
US
Waystar Holding Corp
NASDAQ:WAY
6.3B USD 7 -120.4 24.7 68.7
JP
M3 Inc
TSE:2413
934B JPY 3.8 23.9 11.8 13.8
US
Inspire Medical Systems Inc
NYSE:INSP
5.6B USD 7.4 170.2 283.7 386.4
SE
Sectra AB
STO:SECT B
53.5B SEK 29.5 119.5 -71.4 -71.4
US
Vocera Communications Inc
F:V00
2.4B EUR 10.7 -294.8 239.5 3 835.2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
16.7B CNY 5.1 45.1 33.2 33.2
P/E Multiple
Earnings Growth P/E to Growth
FR
Cegedim SA
PAR:CGM
Average P/E: 104.2
87.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
54.6
142%
0.4
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
322.2
131%
2.5
US
Doximity Inc
NYSE:DOCS
62
78%
0.8
US
W
Waystar Holding Corp
NASDAQ:WAY
Negative Multiple: -120.4 N/A N/A
JP
M3 Inc
TSE:2413
23.9
33%
0.7
US
Inspire Medical Systems Inc
NYSE:INSP
170.2
N/A N/A
SE
Sectra AB
STO:SECT B
119.5
81%
1.5
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -294.8 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
45.1
142%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Cegedim SA
PAR:CGM
Average EV/EBITDA: 93.7
3.8
33%
0.1
US
Veeva Systems Inc
NYSE:VEEV
46.3
221%
0.2
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
225
130%
1.7
US
Doximity Inc
NYSE:DOCS
47.1
92%
0.5
US
W
Waystar Holding Corp
NASDAQ:WAY
24.7
N/A N/A
JP
M3 Inc
TSE:2413
11.8
24%
0.5
US
Inspire Medical Systems Inc
NYSE:INSP
283.7
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -71.4 N/A N/A
US
V
Vocera Communications Inc
F:V00
239.5
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
33.2
143%
0.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Cegedim SA
PAR:CGM
Average EV/EBIT: 472.4
20.3
100%
0.2
US
Veeva Systems Inc
NYSE:VEEV
49
239%
0.2
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
225
122%
1.8
US
Doximity Inc
NYSE:DOCS
49.5
102%
0.5
US
W
Waystar Holding Corp
NASDAQ:WAY
68.7
N/A N/A
JP
M3 Inc
TSE:2413
13.8
N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
386.4
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -71.4 N/A N/A
US
V
Vocera Communications Inc
F:V00
3 835.2
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
33.2
123%
0.3

See Also

Summary
CGM intrinsic value, competitors valuation, and company profile.
DCF Valuation
CGM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CGM stock valuation using valuation multiples.
Wall Street Estimates
CGM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CGM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.